The efficacy of preservation of upper limb lymphatic pathways in breast cancer surgery for reduction of lymphedema

• Register: ChiCTR
• Last refreshed on: 18 April 2017
• Main ID: ChiCTR-ICR-15006123
• Date of registration: 2014-03-17
• Prospective Registration: Yes
• Primary sponsor: Hangzhou first people's hospital
• Public title: The efficacy of preservation of upper limb lymphatic pathways in breast cancer surgery for reduction of lymphedema
• Scientific title: The efficacy of preservation of upper limb lymphatic pathways in breast cancer surgery for reduction of lymphedema
• Date of first enrolment: 2014-07-01
• Target sample size: conventional group:100;experimental group:100;
• Recruitment status: Recruiting
• URL: http://www.chictr.org.cn/showproj.aspx?proj=10612
• Study type: Interventional study
• Study design: Randomized parallel controlled trial
• Phase: New Treatment Measure Clinical Study

Countries of recruitment

China

Contacts

• Name: Zhou Jun
• Affiliation: Hangzhou first people's hospital

• Name: Liu Jian

Key inclusion & exclusion criteria

Inclusion criteria: 1. Early primary breast cance;
2. Axillary lymph node dissection.
Exclusion criteria: 1. upper extremity surgery medical history;
2. Indocyanine green allergy.

Age minimum: 18
Age maximum: 70
Gender: Both

Health Condition(s) or Problem(s) studied

breast cancer

Intervention(s)

conventional group:resection upper back lymph nodes;experimental group:reserve upper back lymph nodes;

Primary Outcome(s)

circumference of upper limb;

Secondary Outcome(s)

The upper extremity lymph node positive rate;

Source(s) of Monetary Support

Health and family planning commission of zhejiang province And Hangzhou first people's hospital